脊椎針の世界市場（～2030年）

世界の脊椎針の市場規模は、予測期間中にCAGRで10.37%の健全な成長が予測されています。脊椎疾患にかかりやすい高齢人口の増加による、脊椎狭窄症や神経疾患の流行が、市場の発展を促進しています。

当レポートでは、世界の脊椎針市場について調査分析し、市場力学と見通し、セグメント分析、企業プロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場のイントロダクション

第3章 調査手法

第4章 市場力学

• 概要
• 促進要因
  • 脊柱管狭窄症と神経疾患の流行
  • 脊椎疾患になりやすい高齢人口の増加
  • 脊椎手術における脊椎針の利用の増加
• 抑制要因
  • 脊椎手術に伴う副作用と合併症
  • 厳しい政府規制
• 機会
  • 提携、買収、製品の発売の増加

第5章 市場要因の分析

• バリューチェーン分析
  • 研究開発、設計
  • 製造
  • 流通、マーケティング、販売
  • 販売後モニタリング
• ポーターのファイブフォース分析モデル
• COVID-19の影響の分析
  • 脊椎手術に対する影響
  • 脊椎外科医に対する影響
  • 臨床試験に対する影響

第6章 世界の脊椎針市場：タイプ別

• イントロダクション
• 非外傷性針
• 指向性脊椎針
• ペンシルポイント針

第7章 世界の脊椎針市場：用途別

• イントロダクション
• 治療
• 診断

第8章 脊椎針市場：エンドユーザー別

• 概要
• 病院、診療所
• 診断センター
• 研究
• 専門センター

第9章 世界の脊椎針市場：地域別

• 概要
• 米国
  • 北米
  • ラテンアメリカ
• 欧州
  • 西欧
  • 東欧
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア
  • その他のアジア太平洋
• 中東・アフリカ
  • 中東
  • アフリカ

第10章 競合情勢

• 概要
• 競合ベンチマーキング
• 世界の脊椎針市場における主な成長戦略
• 世界の脊椎針市場における開発数の主要企業
• 主な開発の分析
• 主な発展と成長戦略
  • 製品の発売/製品の承認
  • 合併/買収
  • 拡張/投資
• 財務マトリクス
  • 売上と営業利益率（2020年）
  • 研究開発費（2020年）

第11章 企業プロファイル

• STRYKER CORPORATION
• BOSTON SCIENTIFIC CORPORATION
• B. BRAUN MELSUNGEN AG
• MEDTRONIC PLC
• SMITHS MEDICAL
• BECTON, DICKINSON, AND COMPANY
• EXELINT INTERNATIONAL, CO.
• ARGON MEDICAL
• MYCO MEDICAL
• COOK MEDICAL

第12章 付録

LIST OF TABLES

• TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
• TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
• TABLE 3 GLOBAL: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 4 GLOBAL: SPINAL NEEDLES MARKET, FOR ATRAUMATIC NEEDLES, BY REGIONS, 2018-2027 (USD MILLION)
• TABLE 5 GLOBAL: SPINAL NEEDLES MARKET, FOR DIRECTIONAL SPINAL NEEDLES, BY REGIONS, 2018-2027 (USD MILLION)
• TABLE 6 GLOBAL: SPINAL NEEDLES MARKET, FOR PENCIL-POINT NEEDLES, BY REGIONS, 2018-2027 (USD MILLION)
• TABLE 7 GLOBAL: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 8 GLOBAL: SPINAL NEEDLES MARKET, FOR THERAPEUTIC, BY REGIONS, 2018-2027 (USD MILLION)
• TABLE 9 GLOBAL: SPINAL NEEDLES MARKET, FOR DIAGNOSTIC, BY REGIONS, 2018-2027 (USD MILLION)
• TABLE 10 GLOBAL: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
• TABLE 11 GLOBAL: SPINAL NEEDLES MARKET, FOR HOSPITALS & CLINICS, BY REGIONS, 2018-2027 (USD MILLION)
• TABLE 12 GLOBAL: SPINAL NEEDLES MARKET, FOR DIAGNOSTICS CENTERS, BY REGIONS, 2018-2027 (USD MILLION)
• TABLE 13 GLOBAL: SPINAL NEEDLES MARKET, FOR RESEARCH LABORTORIES, BY REGIONS, 2018-2027 (USD MILLION)
• TABLE 14 GLOBAL: SPINAL NEEDLES MARKET, FOR SPECIALITY CENTERS, BY REGIONS, 2018-2027 (USD MILLION)
• TABLE 15 GLOBAL: SPINAL NEEDLES MARKET, BY REGION, 2018-2027 (USD MILLION)
• TABLE 16 AMERICAS: SPINAL NEEDLES MARKET, BY REGION, 2018-2027 (USD MILLION)
• TABLE 17 AMERICAS: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 18 AMERICAS: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 19 AMERICAS: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
• TABLE 20 NORTH AMERICA: SPINAL NEEDLES MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
• TABLE 21 NORTH AMERICA: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 22 NORTH AMERICA: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 23 NORTH AMERICA: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
• TABLE 24 US: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 25 US: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 26 US: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
• TABLE 27 CANADA: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 28 CANADA: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 29 CANADA: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
• TABLE 30 LATIN AMERICA: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 31 LATIN AMERICA: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 32 LATIN AMERICA: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
• TABLE 33 EUROPE: SPINAL NEEDLES MARKET, BY REGION, 2018-2027 (USD MILLION)
• TABLE 34 EUROPE: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 35 EUROPE: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 36 EUROPE: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
• TABLE 37 WESTERN EUROPE: SPINAL NEEDLES MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
• TABLE 38 WESTERN EUROPE: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 39 WESTERN EUROPE: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 40 WESTERN EUROPE: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
• TABLE 41 GERMANY: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 42 GERMANY: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 43 GERMANY: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
• TABLE 44 FRANCE: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 45 FRANCE: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 46 FRANCE: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
• TABLE 47 UK: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 48 UK: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 49 UK: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
• TABLE 50 ITALY: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 51 ITALY: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 52 ITALY: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
• TABLE 53 SPAIN: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 54 SPAIN: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 55 SPAIN: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
• TABLE 56 REST OF WESTERN EUROPE: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 57 REST OF WESTERN EUROPE: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 58 REST OF WESTERN EUROPE: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
• TABLE 59 EASTERN EUROPE: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 60 EASTERN EUROPE: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 61 EASTERN EUROPE: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
• TABLE 62 ASIA PACIFIC: SPINAL NEEDLES MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
• TABLE 63 ASIA PACIFIC: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 64 ASIA PACIFIC: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 65 ASIA PACIFIC: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
• TABLE 66 CHINA: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 67 CHINA: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 68 CHINA: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
• TABLE 69 INDIA: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 70 INDIA: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 71 INDIA: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
• TABLE 72 JAPAN: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 73 JAPAN: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 74 JAPAN: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
• TABLE 75 SOUTH KOREA: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 76 SOUTH KOREA: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 77 SOUTH KOREA: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
• TABLE 78 AUSTRALIA: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 79 AUSTRALIA: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 80 AUSTRALIA: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
• TABLE 81 REST OF ASIA PACIFIC: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 82 REST OF ASIA PACIFIC: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 83 REST OF ASIA PACIFIC: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
• TABLE 84 MIDDLE EAST & AFRICA: SPINAL NEEDLES MARKET, BY REGION, 2018-2027 (USD MILLION)
• TABLE 85 MIDDLE EAST & AFRICA: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 86 MIDDLE EAST & AFRICA: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 87 MIDDLE EAST & AFRICA: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
• TABLE 88 MIDDLE EAST: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 89 MIDDLE EAST: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 90 MIDDLE EAST: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
• TABLE 91 AFRICA: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 92 AFRICA: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 93 AFRICA: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
• TABLE 94 MAJOR PLAYERS IN THE GLOBAL SPINAL NEEDLES MARKET
• TABLE 95 MOST ACTIVE PLAYER IN THE GLOBAL SPINAL NEEDLES MARKET
• TABLE 96 PRODUCT LAUNCH/PRODUCT APPROVAL
• TABLE 97 MERGER/ACQUISITION
• TABLE 98 EXPANSION/INVESTMENT
• TABLE 99 STRYKER CORPORATION: PRODUCTS/SERVICES OFFERED
• TABLE 100 STRYKER CORPORATION: KEY DEVELOPMENTS
• TABLE 101 BOSTON SCIENTIFIC CORPORATION: PRODUCTS/SERVICES OFFERED
• TABLE 102 BOSTON SCIENTIFIC CORPORATION: KEY DEVELOPMENTS
• TABLE 103 B. BRAUN MELSUNGEN AG: PRODUCTS/SERVICES OFFERED
• TABLE 104 B. BRAUN MELSUNGEN AG: KEY DEVELOPMENTS
• TABLE 105 MEDTRONIC PLC: PRODUCTS/SERVICES OFFERED
• TABLE 106 MEDTRONIC PLC: KEY DEVELOPMENTS
• TABLE 107 SMITHS MEDICAL: PRODUCTS/SERVICES OFFERED
• TABLE 108 SMITHS MEDICAL: KEY DEVELOPMENTS
• TABLE 109 BECTON, DICKINSON, AND COMPANY: PRODUCTS/SERVICES OFFERED
• TABLE 110 BECTON, DICKINSON, AND COMPANY: KEY DEVELOPMENTS
• TABLE 111 EXELINT INTERNATIONAL, CO.: PRODUCTS/SERVICES OFFERED
• TABLE 112 ARGON MEDICAL: PRODUCTS/SERVICES OFFERED
• TABLE 113 ARGON MEDICAL: KEY DEVELOPMENTS
• TABLE 114 MYCO MEDICAL: PRODUCTS/SERVICES OFFERED
• TABLE 115 COOK MEDICAL: PRODUCTS/SERVICES OFFERED
• TABLE 116 COOK MEDICAL: KEY DEVELOPMENTS

LIST OF FIGURES

• FIGURE 1 MARKET SYNOPSIS
• FIGURE 2 GLOBAL SPINAL NEEDLES MARKET
• FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
• FIGURE 4 MARKET DYNAMICS: GLOBAL SPINAL NEEDLES MARKET
• FIGURE 5 DRIVERS: IMPACT ANALYSIS
• FIGURE 6 RESTRAINTS: IMPACT ANALYSIS
• FIGURE 7 VALUE CHAIN ANALYSIS OF GLOBAL SPINAL NEEDLES MARKET
• FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL SPINAL NEEDLES MARKET
• FIGURE 9 GLOBAL SPINAL NEEDLES MARKET, BY TYPE, 2020 & 2027 (USD MILLION)
• FIGURE 10 GLOBAL SPINAL NEEDLES MARKET, BY APPLICATION, 2020 & 2027 (USD MILLION)
• FIGURE 11 GLOBAL SPINAL NEEDLES MARKET, BY END USER, 2020 & 2027 (USD MILLION)
• FIGURE 12 GLOBAL: SPINAL NEEDLES MARKET, BY REGION 2020 & 2027 (USD MILLION)
• FIGURE 13 GLOBAL: SPINAL NEEDLES MARKET SHARE (%), BY REGION, 2020
• FIGURE 14 AMERICAS: SPINAL NEEDLES MARKET SHARE (%), BY REGION 2020
• FIGURE 15 NORTH AMERICA: SPINAL NEEDLES MARKET SHARE (%), BY COUNTRY 2020
• FIGURE 16 EUROPE: SPINAL NEEDLES MARKET SHARE (%), BY REGION, 2020
• FIGURE 17 WESTERN EUROPE: SPINAL NEEDLES MARKET SHARE (%), BY COUNTRY, 2020
• FIGURE 18 ASIA PACIFIC: SPINAL NEEDLES MARKET SHARE (%), BY COUNTRY 2020
• FIGURE 19 MIDDLE EAST & AFRICA: SPINAL NEEDLES MARKET SHARE (%), BY REGION, 2020
• FIGURE 20 BENCHMARKING OF MAJOR COMPETITORS
• FIGURE 21 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL SPINAL NEEDLES MARKET
• FIGURE 22 GLOBAL SPINAL NEEDLES MARKET: COMPETITIVE LANDSCAPE
• FIGURE 23 SALES (USD MILLION) AND OPERATING PROFIT MARGIN (%), 2020
• FIGURE 24 R&D EXPENDITURE (USD MILLION), 2020
• FIGURE 25 STRYKER CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 26 STRYKER CORPORATION: SWOT ANALYSIS
• FIGURE 27 BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 28 BOSTON SCIENTIFIC CORPORATION: SWOT ANALYSIS
• FIGURE 29 B. BRAUN MELSUNGEN AG: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 30 B. BRAUN MELSUNGEN AG: SWOT ANALYSIS
• FIGURE 31 MEDTRONIC PLC: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 32 B MEDTRONIC PLC: SWOT ANALYSIS
• FIGURE 33 SMITHS GROUP PLC: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 34 SMITHS MEDICAL: SWOT ANALYSIS
• FIGURE 35 BECTON, DICKINSON, AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 36 BECTON, DICKINSON, AND COMPANY: SWOT ANALYSIS
• FIGURE 37 EXELINT INTERNATIONAL, CO.: SWOT ANALYSIS
• FIGURE 38 ARGON MEDICAL: SWOT ANALYSIS
• FIGURE 39 MYCO MEDICAL: SWOT ANALYSIS
• FIGURE 40 COOK MEDICAL: SWOT ANALYSIS

Market Overview

Spinal Needles Market is projected to register a healthy CAGR of 10.37% during the forecast period. The rising geriatric populace is inclined to spinal problems, and the rising predominance of spinal stenosis and neurological issues is driving the market development.

Spinal stenosis is an ailment portrayed by the pressure of nerve roots by a few neurotic variables connected with rope brokenness inspired by a mix of mechanical pressure and degenerative precariousness. The side effect of spinal stenosis incorporates shortcoming, torment, and deadness. An examination article distributed in the American Organization of Negligibly Obtrusive Medical procedure (AIMIS) in 2018 portrays that roughly 250,000-500,000 experience the ill effects of spinal stenosis addressing 1 for each 1000 people more established than 65 years and around 5 of each and every 1,000 people more seasoned than 50 years in America. This rising maturing populace experiencing spinal stenosis plainly requests a compelling careful mediation. Consequently, this component helps the market development of spinal needles.

Besides, a rising number of neurological issues likewise go about as a driving component for market development. As per the information distributed in Front Reach Spine and Neurosurgery in 2018, more than 600 neurological circumstances have been recognized, influencing many millions globally.

Market Segmentation

The Spinal Needles Market segmentation, based on type, includes pencil-point needles, and directional Based on an application the market is divided into therapeutic, and diagnostic. The Spinal Needles Market segmentation is based on end-user that includes hospitals & clinics, diagnostic centers, research laboratories, and others.

Regional Insights

The Europe Leavening Agents market represented USD 31,613.76 million in 2021 and is supposed to display a 6.04% CAGR during the review time frame. the rising inclination for clean-name fixings and the quick development of the bread kitchen industry is projected to introduce rewarding development and venture valuable open doors for market players during the survey time frame.

Besides, the German leavening agents market held the biggest piece of the pie, and the France leavening agents market was the quickest developing business sector in the European region.

North America's leavening agents market represents the second-biggest piece of the pie because of the Rising interest in regular food fixings. Further, the US leavening agents market held the biggest piece of the pie, and the Canadian leavening agents market likewise holds a huge piece of the pie in the North American region.

The Asia-Pacific leavening agents market is supposed to develop at a CAGR of 7.07% from 2022 to 2030. This is because of changing purchaser dietary propensities for different applications. Also, the China leavening agents market held the biggest piece of the pie, and the India leavening agents market was the quickest developing business sector in the Asia-Pacific region.

Major Players

Key Companies in the Spinal Needles Market Include Boston Scientific Corporation (US), Stryker Corporation (US), Becton, Braun Melsungen AG (US), Smith's Medical (US), Myco Medical (US), Dickinson, and Company (US), Argon Medical (US), and Exelint International, Co. (US).

TABLE OF CONTENTS

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

• 2.1 SCOPE OF THE STUDY
• 2.2 RESEARCH OBJECTIVE
• 2.3 MARKET STRUCTURE
• 2.4 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

• 3.1 DATA MINING
• 3.2 SECONDARY RESEARCH
• 3.3 PRIMARY RESEARCH
• 3.4 BREAKDOWN OF PRIMARY RESPONDENTS
• 3.5 FORECASTING TECHNIQUES
• 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
  • 3.6.1 BOTTOM-UP APPROACH
  • 3.6.2 TOP-DOWN APPROACH
• 3.7 DATA TRIANGULATION
• 3.8 VALIDATION

4 MARKET DYNAMICS

• 4.1 OVERVIEW
• 4.2 DRIVERS
  • 4.2.1 INCREASING PREVALENCE OF SPINAL STENOSIS AND NEUROLOGICAL DISORDERS
  • 4.2.2 RISING GERIATRIC POPULATION PRONE TO SPINAL DISORDERS
  • 4.2.3 INCREASING APPLICATION OF SPINAL NEEDLES FOR SPINE SURGERIES
• 4.3 RESTRAINTS
  • 4.3.1 SIDE EFFECTS AND COMPLICATIONS ASSOCIATED WITH SPINE SURGERY
  • 4.3.2 STRINGENT GOVERNMENT REGULATIONS
• 4.4 OPPORTUNITIES
  • 4.4.1 INCREASING NUMBER OF COLLABORATIONS, ACQUISITIONS, AND PRODUCT LAUNCHES

5 MARKET FACTOR ANALYSIS

• 5.1 VALUE CHAIN ANALYSIS
  • 5.1.1 R&D AND DESIGNING
  • 5.1.2 MANUFACTURING
  • 5.1.3 DISTRIBUTION, MARKETING, & SALES
  • 5.1.4 POST-SALES MONITORING
• 5.2 PORTER'S FIVE FORCES MODEL
  • 5.2.1 THREAT OF NEW ENTRANTS
  • 5.2.2 BARGAINING POWER OF SUPPLIERS
  • 5.2.3 THREAT OF SUBSTITUTES
  • 5.2.4 BARGAINING POWER OF BUYERS
  • 5.2.5 INTENSITY OF RIVALRY
• 5.3 COVID-19 IMPACT ANALYSIS
  • 5.3.1 IMPACT ON SPINAL SURGERY
  • 5.3.2 IMPACT ON SPINE SURGEONS
  • 5.3.3 IMPACT ON CLINICAL TRIALS

6 GLOAL SPINAL NEEDLES MARKET, BY TYPE

• 6.1 INTRODUCTION
• 6.2 ATRAUMATIC NEEDLES
• 6.3 DIRECTIONAL SPINAL NEEDLES
• 6.4 PENCIL-POINT NEEDLES

7 GLOBAL SPINAL NEEDLES MARKET, BY APPLICATION

• 7.1 INTRODUCTION
• 7.2 THERAPEUTIC
• 7.3 DIAGNOSTIC

8 SPINAL NEEDLES MARKET, BY END USER

• 8.1 OVERVIEW
• 8.2 HOSPITALS & CLINICS
• 8.3 DIAGNOSTIC CENTERS
• 8.4 RESEARCH LABORATORIES
• 8.5 SPECIALTY CENTERS

9 GLOBAL SPINAL NEEDLES MARKET, BY REGION

• 9.1 OVERVIEW
• 9.2 AMERICAS
  • 9.2.1 NORTH AMERICA
    • 9.2.1.1 US
    • 9.2.1.2 CANADA
  • 9.2.2 LATIN AMERICA
• 9.3 EUROPE
  • 9.3.1 WESTERN EUROPE
    • 9.3.1.1 GERMANY
    • 9.3.1.2 FRANCE
    • 9.3.1.3 UK
    • 9.3.1.4 ITALY
    • 9.3.1.5 SPAIN
    • 9.3.1.6 REST OF WESTERN EUROPE
  • 9.3.2 EASTERN EUROPE
• 9.4 ASIA PACIFIC
  • 9.4.1 CHINA
  • 9.4.2 INDIA
  • 9.4.3 JAPAN
  • 9.4.4 SOUTH KOREA
  • 9.4.5 AUSTRALIA
  • 9.4.6 REST OF ASIA PACIFIC
• 9.5 MIDDLE EAST & AFRICA
  • 9.5.1 MIDDLE EAST
  • 9.5.2 AFRICA

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
• 10.2 COMPETITIVE BENCHMARKING
• 10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL SPINAL NEEDLES MARKET
• 10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL SPINAL NEEDLES MARKET
• 10.5 KEY DEVELOPMENT ANALYSIS
• 10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
  • 10.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL
  • 10.6.2 MERGER/ACQUISITION
  • 10.6.3 EXPANSION/INVESTMENT
• 10.7 FINANCIAL MATRIX
  • 10.7.1 SALES (USD MILLION) AND OPERATING PROFIT MARGIN (%), 2020
  • 10.7.2 R&D EXPENDITURE (USD MILLION), 2020

11 COMPANY PROFILES

• 11.1 STRYKER CORPORATION
  • 11.1.1 COMPANY OVERVIEW
  • 11.1.2 FINANCIAL OVERVIEW
  • 11.1.3 PRODUCTS OFFERED
  • 11.1.4 KEY DEVELOPMENTS
  • 11.1.5 SWOT ANALYSIS
  • 11.1.6 KEY STRATEGIES
• 11.2 BOSTON SCIENTIFIC CORPORATION
  • 11.2.1 COMPANY OVERVIEW
  • 11.2.2 FINANCIAL OVERVIEW
  • 11.2.3 PRODUCTS/SERVICES OFFERED
  • 11.2.4 KEY DEVELOPMENTS
  • 11.2.5 SWOT ANALYSIS
  • 11.2.6 KEY STRATEGIES
• 11.3 B. BRAUN MELSUNGEN AG
  • 11.3.1 COMPANY OVERVIEW
  • 11.3.2 FINANCIAL OVERVIEW
  • 11.3.3 PRODUCTS/SERVICES OFFERED
  • 11.3.4 KEY DEVELOPMENTS
  • 11.3.5 SWOT ANALYSIS
  • 11.3.6 KEY STRATEGIES
• 11.4 MEDTRONIC PLC
  • 11.4.1 COMPANY OVERVIEW
  • 11.4.2 FINANCIAL OVERVIEW
  • 11.4.3 PRODUCTS/SERVICES OFFERED
  • 11.4.4 KEY DEVELOPMENTS
  • 11.4.5 SWOT ANALYSIS
  • 11.4.6 KEY STRATEGIES
• 11.5 SMITHS MEDICAL
  • 11.5.1 COMPANY OVERVIEW
  • 11.5.2 FINANCIAL OVERVIEW
  • 11.5.3 PRODUCTS/SERVICES OFFERED
  • 11.5.4 KEY DEVELOPMENTS
  • 11.5.5 SWOT ANALYSIS
  • 11.5.6 KEY STRATEGIES
• 11.6 BECTON, DICKINSON, AND COMPANY
  • 11.6.1 COMPANY OVERVIEW
  • 11.6.2 FINANCIAL OVERVIEW
  • 11.6.3 PRODUCTS OFFERED
  • 11.6.4 KEY DEVELOPMENTS
  • 11.6.5 SWOT ANALYSIS
  • 11.6.6 KEY STRATEGIES
• 11.7 EXELINT INTERNATIONAL, CO.
  • 11.7.1 COMPANY OVERVIEW
  • 11.7.2 FINANCIAL OVERVIEW
  • 11.7.3 PRODUCTS OFFERED
  • 11.7.4 KEY DEVELOPMENTS
  • 11.7.5 SWOT ANALYSIS
  • 11.7.6 KEY STRATEGIES
• 11.8 ARGON MEDICAL
  • 11.8.1 COMPANY OVERVIEW
  • 11.8.2 FINANCIAL OVERVIEW
  • 11.8.3 PRODUCTS OFFERED
  • 11.8.4 KEY DEVELOPMENTS
  • 11.8.5 SWOT ANALYSIS
  • 11.8.6 KEY STRATEGIES
• 11.9 MYCO MEDICAL
  • 11.9.1 COMPANY OVERVIEW
  • 11.9.2 FINANCIAL OVERVIEW
  • 11.9.3 PRODUCTS OFFERED
  • 11.9.4 KEY DEVELOPMENTS
  • 11.9.5 SWOT ANALYSIS
  • 11.9.6 KEY STRATEGIES
• 11.10 COOK MEDICAL
  • 11.10.1 COMPANY OVERVIEW
  • 11.10.2 FINANCIAL OVERVIEW
  • 11.10.3 PRODUCTS OFFERED
  • 11.10.4 KEY DEVELOPMENTS
  • 11.10.5 SWOT ANALYSIS
  • 11.10.6 KEY STRATEGIES

12 APPENDIX

• 12.1 REFERENCES
• 12.2 RELATED REPORTS